Drug Type Immunoglobulin |
Synonyms Human Normal Immunoglobulin(Yuanda Shuyang Pharmaceutical) |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1998), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Autoimmune Diseases | China | 01 Jan 1998 | |
Hepatitis | China | 01 Jan 1998 | |
Immunoglobulin deficiency | China | 01 Jan 1998 | |
Measles | China | 01 Jan 1998 | |
Secondary immunodeficiencies | China | 01 Jan 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Purpura, Thrombocytopenic, Idiopathic | Phase 3 | China | 05 Aug 2024 | |
Primary Immunodeficiency Diseases | Phase 3 | - | 01 Apr 2024 |